vs
Apellis Pharmaceuticals, Inc.（APLS）与Genie Energy Ltd.（GNE）财务数据对比。点击上方公司名可切换其他公司
Apellis Pharmaceuticals, Inc.的季度营收约是Genie Energy Ltd.的1.4倍（$199.9M vs $138.3M），Genie Energy Ltd.净利率更高（4.9% vs -29.5%，领先34.4%），Genie Energy Ltd.同比增速更快（23.6% vs -5.9%），过去两年Genie Energy Ltd.的营收复合增速更高（14.8% vs 7.7%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
Genie Energy Ltd.是一家总部位于美国新泽西州纽瓦克的能源企业，作为控股公司，旗下业务涵盖零售能源、国际零售能源、能源服务以及油气业务，迈克尔·斯坦因现任该公司首席执行官。
APLS vs GNE — 直观对比
营收规模更大
APLS
是对方的1.4倍
$138.3M
营收增速更快
GNE
高出29.5%
-5.9%
净利率更高
GNE
高出34.4%
-29.5%
两年增速更快
GNE
近两年复合增速
7.7%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $138.3M |
| 净利润 | $-59.0M | $6.7M |
| 毛利率 | — | 21.7% |
| 营业利润率 | -25.6% | 5.0% |
| 净利率 | -29.5% | 4.9% |
| 营收同比 | -5.9% | 23.6% |
| 净利润同比 | -62.2% | -33.9% |
| 每股收益（稀释后） | $-0.40 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSGNE
| Q4 25 | $199.9M | — | ||
| Q3 25 | $458.6M | $138.3M | ||
| Q2 25 | $178.5M | $105.3M | ||
| Q1 25 | $166.8M | $136.8M | ||
| Q4 24 | $212.5M | $102.9M | ||
| Q3 24 | $196.8M | $111.9M | ||
| Q2 24 | $199.7M | $90.7M | ||
| Q1 24 | $172.3M | $119.7M |
净利润APLSGNE
| Q4 25 | $-59.0M | — | ||
| Q3 25 | $215.7M | $6.7M | ||
| Q2 25 | $-42.2M | $2.8M | ||
| Q1 25 | $-92.2M | $10.3M | ||
| Q4 24 | $-36.4M | $-15.3M | ||
| Q3 24 | $-57.4M | $10.2M | ||
| Q2 24 | $-37.7M | $9.6M | ||
| Q1 24 | $-66.4M | $8.1M |
毛利率APLSGNE
| Q4 25 | — | — | ||
| Q3 25 | — | 21.7% | ||
| Q2 25 | — | 22.3% | ||
| Q1 25 | — | 27.3% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | — | 33.9% | ||
| Q2 24 | — | 36.8% | ||
| Q1 24 | — | 28.2% |
营业利润率APLSGNE
| Q4 25 | -25.6% | — | ||
| Q3 25 | 48.7% | 5.0% | ||
| Q2 25 | -18.6% | 1.9% | ||
| Q1 25 | -50.0% | 9.4% | ||
| Q4 24 | -12.3% | -20.2% | ||
| Q3 24 | -24.0% | 10.4% | ||
| Q2 24 | -14.7% | 11.6% | ||
| Q1 24 | -36.0% | 8.2% |
净利率APLSGNE
| Q4 25 | -29.5% | — | ||
| Q3 25 | 47.0% | 4.9% | ||
| Q2 25 | -23.6% | 2.7% | ||
| Q1 25 | -55.3% | 7.5% | ||
| Q4 24 | -17.1% | -14.9% | ||
| Q3 24 | -29.2% | 9.1% | ||
| Q2 24 | -18.9% | 10.6% | ||
| Q1 24 | -38.5% | 6.8% |
每股收益（稀释后）APLSGNE
| Q4 25 | $-0.40 | — | ||
| Q3 25 | $1.67 | $0.26 | ||
| Q2 25 | $-0.33 | $0.11 | ||
| Q1 25 | $-0.74 | $0.40 | ||
| Q4 24 | $-0.30 | $-0.58 | ||
| Q3 24 | $-0.46 | $0.38 | ||
| Q2 24 | $-0.30 | $0.36 | ||
| Q1 24 | $-0.54 | $0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $109.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $198.8M |
| 总资产 | $1.1B | $394.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSGNE
| Q4 25 | $466.2M | — | ||
| Q3 25 | $479.2M | $109.8M | ||
| Q2 25 | $370.0M | $106.0M | ||
| Q1 25 | $358.4M | $118.3M | ||
| Q4 24 | $411.3M | $110.1M | ||
| Q3 24 | $396.9M | $141.8M | ||
| Q2 24 | $360.1M | $126.8M | ||
| Q1 24 | $325.9M | $106.9M |
总债务APLSGNE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $93.1M | — |
股东权益APLSGNE
| Q4 25 | $370.1M | — | ||
| Q3 25 | $401.2M | $198.8M | ||
| Q2 25 | $156.3M | $197.0M | ||
| Q1 25 | $164.2M | $198.0M | ||
| Q4 24 | $228.5M | $190.5M | ||
| Q3 24 | $237.1M | $211.1M | ||
| Q2 24 | $264.3M | $202.1M | ||
| Q1 24 | $266.7M | $192.9M |
总资产APLSGNE
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $394.1M | ||
| Q2 25 | $821.4M | $383.1M | ||
| Q1 25 | $807.3M | $384.4M | ||
| Q4 24 | $885.1M | $371.3M | ||
| Q3 24 | $901.9M | $341.7M | ||
| Q2 24 | $904.5M | $322.8M | ||
| Q1 24 | $831.9M | $328.3M |
负债/权益比APLSGNE
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $13.9M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | — |
| 自由现金流率自由现金流/营收 | -7.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 2.07× |
| 过去12个月自由现金流最近4个季度 | $45.0M | — |
8季度趋势，按日历期对齐
经营现金流APLSGNE
| Q4 25 | $-14.2M | — | ||
| Q3 25 | $108.5M | $13.9M | ||
| Q2 25 | $4.4M | $1.1M | ||
| Q1 25 | $-53.4M | $15.3M | ||
| Q4 24 | $19.4M | $13.0M | ||
| Q3 24 | $34.1M | $24.4M | ||
| Q2 24 | $-8.3M | $20.4M | ||
| Q1 24 | $-133.0M | $12.9M |
自由现金流APLSGNE
| Q4 25 | $-14.3M | — | ||
| Q3 25 | $108.3M | — | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | $-53.4M | $13.6M | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | — | $21.9M | ||
| Q2 24 | $-8.4M | $20.1M | ||
| Q1 24 | $-133.3M | $11.7M |
自由现金流率APLSGNE
| Q4 25 | -7.1% | — | ||
| Q3 25 | 23.6% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | -32.0% | 9.9% | ||
| Q4 24 | 9.1% | — | ||
| Q3 24 | — | 19.6% | ||
| Q2 24 | -4.2% | 22.1% | ||
| Q1 24 | -77.3% | 9.8% |
资本支出强度APLSGNE
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | 1.3% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | 2.2% | ||
| Q2 24 | 0.0% | 0.4% | ||
| Q1 24 | 0.2% | 1.0% |
现金转化率APLSGNE
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | 2.07× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 1.49× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.39× | ||
| Q2 24 | — | 2.12× | ||
| Q1 24 | — | 1.59× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
GNE
| Sales Channel Directly To Consumer | $108.8M | 79% |
| Sales Channel Through Intermediary | $23.5M | 17% |
| Genie Renewables GREW | $6.0M | 4% |
